Successfully Integrating Radium Ra 223 Dichloride Injection Into a Urology Practice

di McMahon, Gregory C., Brown, Gordon A.
Pubblicato in Rev Urol (2017)

Utilization of individualized prostate cancer and genomic biomarkers for the practicing urologist

di McMahon, Gregory C., Brown, Gordon A., Mueller, Thomas J.
Pubblicato in Rev Urol (2017)

Impact of the US Preventive Services Task Force Grade D Recommendation: Assessment of Evaluations for Elevated Prostate-specific Antigen and Prostate Biopsies in a Large Urology Gr...

di McGinley, Kathleen F, McMahon, Gregory C, Brown, Gordon A
Pubblicato in Rev Urol (2015)

PROSTATIC URETHRAL BIOPSY HAS LIMITED UTILITY IN COUNSELING PATIENTS REGARDING FINAL URETHRAL MARGIN STATUS DURING ORTHOTOPIC NEOBLADDER RECONSTRUCTION

di Kassouf, Wassim, Spiess, Philippe E., Brown, Gordon A., Liu, Ping, Grossman, H. Barton, Dinney, Colin P. N., Kamat, Ashish M.
Pubblicato in J Urol (2008)

Barriers to accessing urethroplasty

di Consolo, Michael J., Syed, Kirin K., Robison, Christopher, McFadden, Jacob, Shalowitz, David I., Brown, Gordon A., Sussman, David O., Figler, Bradley D.
Pubblicato in Rev Urol (2016)

P0 Stage at Radical Cystectomy for Bladder Cancer is Associated with Improved Outcome Independent of Traditional Clinical Risk Factors

di Kassouf, Wassim, Spiess, Philippe E., Brown, Gordon A., Munsell, Mark F., Grossman, H. Barton, Siefker-Radtke, Arlene, Dinney, Colin P.N., Kamat, Ashish M.
Pubblicazione 2007

ABILITY OF CLINICAL GRADE TO PREDICT FINAL PATHOLOGIC STAGE IN UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA: IMPLICATIONS FOR THERAPY

di BROWN, GORDON A., MATIN, SURENA F., BUSBY, J. ERIK, DINNEY, COLIN P. N., GROSSMAN, H. BARTON, PETTAWAY, CURTIS A., MUNSELL, MARK F., KAMAT, ASHISH M.
Pubblicazione 2007

The Role of Radical Cystectomy in Patients with Clinical T4b Bladder Cancer

di Black, Peter C., Dinney, Colin P.N., Brown, Gordon A., Kassouf, Wassim, Siefker-Radtke, Arlene O., Munsell, Mark F., Grossman, H. Barton, Kamat, Ashish M.
Pubblicazione 2010

Is Vascular Endothelial Growth Factor Modulation a Predictor of the Therapeutic Efficacy of Gefitinib for Bladder Cancer?

di Kassouf, Wassim, Brown, Gordon A., Black, Peter C., Fisher, Mark B., Inamoto, Teruo, Luongo, Tony, Gallagher, David, Bar-Eli, Menashe, McConkey, David J., Adam, Liana, Dinney, Colin P. N.
Pubblicato in J Urol (2008)

DISTINCTIVE EXPRESSION PATTERN OF ErbB FAMILY RECEPTORS SIGNIFY AN AGGRESSIVE VARIANT OF BLADDER CANCER

di Kassouf, Wassim, Black, Peter C., Tuziak, Tomasz, Bondaruk, Jolanta, Lee, Sangkyou, Brown, Gordon A., Adam, Liana, Wei, Caimiao, Baggerly, Keith, Bar-Eli, Menashe, McConkey, David, Czerniak, Bogdan, Dinney, Colin P.
Pubblicazione 2007

Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines

di Shore, Neal D., Antonarakis, Emmanuel S., Cookson, Michael S., Crawford, E. David, Morgans, Alicia K., Albala, David M., Hafron, Jason, Harris, Richard G., Saltzstein, Daniel, Brown, Gordon A., Henderson, Jonathan, Lowentritt, Benjamin, Spier, Jeffrey M., Concepcion, Raoul
Pubblicato in Prostate (2020)